Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.710
-0.100 (-2.62%)
Aug 14, 2025, 11:38 AM - Market open

Prime Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-199.28-195.88-198.13-121.82-165.37-3.41
Upgrade
Depreciation & Amortization
6.846.134.652.220.570.04
Upgrade
Loss (Gain) From Sale of Assets
--0.030.01--
Upgrade
Asset Writedown & Restructuring Costs
----12.02-
Upgrade
Loss (Gain) From Sale of Investments
-0.3-2.61-1.037.881.11-10.87
Upgrade
Stock-Based Compensation
24.7726.0713.916.461.750.39
Upgrade
Other Operating Activities
9.212.3612.518.8384.678.14
Upgrade
Change in Accounts Payable
2.51-5.269.142.461.190.25
Upgrade
Change in Unearned Revenue
67.8870.31----
Upgrade
Change in Other Net Operating Assets
-11.56-33.98-6.49-37.8629.99-0.09
Upgrade
Operating Cash Flow
-99.94-122.87-165.41-131.83-34.08-5.54
Upgrade
Capital Expenditures
-7.06-7.29-8.72-16.1-4.15-0.64
Upgrade
Investment in Securities
59.6974.7527.61-30.34-68.98-
Upgrade
Other Investing Activities
11-0.17-0.67-0.5-0.42
Upgrade
Investing Cash Flow
53.6268.4618.71-47.1-73.63-1.06
Upgrade
Issuance of Common Stock
38.71171.080.66185.54--
Upgrade
Other Financing Activities
624.8--4.04-1.09-0.02
Upgrade
Financing Cash Flow
44.71195.880.66181.49269.2834.93
Upgrade
Net Cash Flow
-1.6141.47-146.052.57161.5728.33
Upgrade
Free Cash Flow
-107-130.16-174.14-147.92-38.23-6.18
Upgrade
Free Cash Flow Margin
-2156.78%-4363.36%----118.68%
Upgrade
Free Cash Flow Per Share
-0.84-1.10-1.91-4.37-2.95-2.34
Upgrade
Levered Free Cash Flow
-103.37-114.57-96.21-117.62-6.8-6.19
Upgrade
Unlevered Free Cash Flow
-103.37-114.57-96.21-117.62-6.8-6.19
Upgrade
Change in Working Capital
58.8331.082.65-35.431.180.16
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q